Website under construction

H&B France, established in Paris in 2015, is a cell therapy company specializing in harnessing the potential of stem cells sourced from the umbilical cord. Key highlights include patented technologies for stem cell and derivative production, boasting two decades of pre-clinical and clinical evidence on placental MSCs (mesenchymal stem cells) by the company's headquarters, Health & Biotech Pharma.

On going activities include the set up of  capacities for Mesenchymal Cells clinical batches production in order to resume clinical development in vascular ischemia, as well as preparation of academic partnership for research programs.

For any request, contact us by email at the following address: [email protected]